Simple, straightforward, care.
Evol Health
WOMEN'S HEALTH
Restore WELLNESS
Aging is a natural process; aging well is a decision we can all make.
Hormonal Balance
Whether you're dealing with perimenopause, menopause, or other imbalances - taking a back seat to hormonal changes is a thing of the past.
Weight Management
Women's bodies are programmed to store fat differently which can make weight management more difficult with age. Prescription medications can help restore metabolism and give you better control over your weight.
Preventative Health
Whether through injury protection, or chronic disease prevention, the experience of aging can be so much more rewarding. Take a preventative approach through hormone and peptide therapies to feel your very best.
Menopause
Menopause is defined as cessation of the menstrual cycle for a period of 12 consecutive months, and a blood serum level of follicle-stimulating hormone (FSH) > 40IU/L. The median age of onset is around 51 years old.
Perimenopause
Perimenopause is characterized by dysfunctional uterine bleeding and a blood serum level of follicle-stimulating hormone (FSH) on day 2 or 3 >10-12IU/L. Physiologic changes and symptoms of perimenopause may appear up to 8 years prior to the onset of menopause.
Vs.
Weight Management
What therapies are available for Weight Management?
The ideal weight loss therapy is different for each patient, at EVOL Health we offer:
Semaglutide
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist used to support weight management, improve blood sugar regulation, and optimize metabolic health. It mimics a hormone naturally produced in the body that regulates appetite, insulin secretion, and digestion.
Tirzepatide
Tirzepatide is an advanced peptide therapy that targets two key hormone pathways - GIP (glucose-dependent insulinotropic popypeptide) and GLP-1 (glucagon-like peptide-1). It is primarily used to support weight loss, improve blood sugar regulation, and enhance metabolic health.
Liraglutide
Liraglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist used to support weight loss, manage type 2 diabetes, and reduce cardiometaboilic risk. It mimics the natural GLP-1 hormone produced in the gut in response to eating, helping regulate blood sugar and appetite.
Metformin
Metformin is an oral prescription medication that helps control blood sugar levels. It's FDA-approved for managing type 2 diabetes but can be prescribed off-label for weight loss.
How Semaglutide is Changing the Weight Loss Industry
Obesity is a significant problem, with approximately 70% of American adults being obese or overweight. This weight problem is a serious health issue that commonly leads to death and other severe health risks like heart disease, stroke, diabetes, and even an increased risk of certain types of cancer. With many weight loss treatments available today, finding the one that works best for you without any side effects can be challenging. Phentermine (Adipex) was regarded as the number one weight loss supplement for years. It is a popular diet pill that suppresses appetite and delivers quick weight loss. However, Adipex is only ever prescribed for short-term use. It also comes with many negative side effects and adverse reactions, so people started looking for alternatives. Today, Semaglutide is available for long-term weight management. It reduces appetite, increases metabolism, reduces body fat, and more. This injection works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas in the brain responsible for regulating appetite and food intake. The medication dose is gradually increased over 16 to 20 weeks to reduce gastrointestinal side effects. In addition, some providers, like EVOL Health, compound the Semaglutide injection with B vitamins to combat nausea. Semaglutide should not be used with other similar products containing other GLP-1 receptor agonists or other products for weight loss, including prescription drugs, over-the-counter drugs, or herbal products.
Semaglutide Treatment Plan*
Patients can expect their provider to increase their medication dose over 16-20 weeks. The average weight loss is 15% of one’s body weight. If you commit to this weight loss injection, it may take up 3-months for optimal results. As with any treatment, results may vary.* This weight loss treatment involves receiving a weekly injection. Patients can complete our self-injection training virtually at no additional charge. Another treatment option available is Semaglutide troches which are taken once daily. The Semglutide troches are about the size of a tic tac and quickly dissolve under the tongue. Semaglutide troches come in different strengths. Patients dissolve 1 troche under the tongue in the morning 15 minutes away from food and drink. Troches have all the same risks and benefits as injectable semaglutide; however, patients typically have fewer side effects than the injectables since they do it daily vs. one large dose once per week. Patients should prepare for regular visits with their provider where their progress is monitored.
Semaglutide Weight Loss Results*
Semaglutide weight loss is ideal for obesity. It subdues hunger, reduces body weight and fat, and improves overall health and wellness. As with any weight loss treatment, results will vary per person.* Committing to a full treatment of Semaglutide is essential for seeing results. Patients need to stick to the plan given to them by their provider and follow a healthy eating program, exercise, and commit to making positive daily changes to reap the full weight loss rewards.
Semaglutide Weight Loss Reviews in Clinical Studies
Semaglutide has been studied extensively in several weight loss reviews and clinical trials. A total of four 68-week trials were conducted on this weight loss injection. Three of the studies were randomized, double-blind, placebo-controlled trials (including 16 weeks of dose increases), and one was a double-blind, placebo-controlled, randomized withdrawal trial where patients receiving the injection continued with the treatment or switched to a placebo. There were more than 2,600 patients receiving Semaglutide in the four studies, while more than 1,500 received a placebo. The results yielded positive results. According to the study, some individuals saw an average weight loss of 12.4% of their initial body weight compared to those receiving the placebo.12
During your consultation, your medical provider will review your health history and current medications and ask you a series of questions about your symptoms
